查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2041706

2034年非處方藥市場預測－按產品、劑型、給藥途徑、通路、最終用戶和地區分類的全球分析

Over the Counter Market Forecasts to 2034 - Global Analysis By Product, Dosage Form, Route of Administration, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，到 2026 年，全球非處方藥 (OTC) 市場規模將達到 2,123 億美元，預計在預測期內將以 7.0% 的複合年成長率成長，到 2034 年將達到 3,648 億美元。

非處方藥（OTC）是指無需醫生處方箋即可購買的藥物。這些藥物在為消費者提供便利有效的解決方案方面發揮著重要作用，例如緩解感冒、身體疼痛、過敏和流感、胃灼熱、痤瘡以及其他一些常見健康問題。成藥的例子包括對乙醯胺酚、阿斯匹靈、制酸劑、減充血劑、抗組織胺藥物和瀉藥。許多國家的監管機構都會對這些藥物進行篩選，以確保其成分安全有效，即使在沒有醫生指導的情況下服用也有效。

根據美國國立衛生研究院 (NIH) 的一份報告，93% 的美國成年人更喜歡在尋求專業幫助之前使用非處方藥治療輕微疾病，85% 的家長更喜歡在尋求專業幫助之前使用非處方藥治療孩子的輕微疾病。

自我治療需求不斷成長

隨著越來越多的人尋求便捷的處方箋治療方法，自我治療變得越來越普遍。這些藥物在藥局、超級市場和便利商店都很容易買到，而且越來越多透過線上平台購買。這種便利性使得消費者能夠輕鬆購買治療輕微疾病和日常健康問題的藥物。此外，與處方藥相比，成藥價格更低也是其一大優點。這種對價格和便利性的關注，使得消費者希望自行處理輕微健康問題的願望得以實現，從而推動了成藥市場的整體成長。

安全隱患

無需處方箋即可購買的成藥）由於消費者自行用藥，存在誤用、濫用和副作用的風險。在缺乏專業醫療指導的情況下，消費者更容易誤用藥物、發生藥物交互作用，或對需要專業介入的疾病產生依賴。這促使監管機構加強監管，以確保消費者安全。副作用和安全問題可能導致產品召回和銷售限制，進而影響市場動態。

全球老化

隨著世界人口老化，與老齡化相關的健康問題和慢性疾病的盛行率也隨之上升。成藥）滿足了老年人日益成長的自我治療需求，為常見疾病提供了便捷且經濟的解決方案。此外，老齡化通常伴隨著多種健康問題，包括關節疼痛、關節炎、心血管疾病和消化器官系統疾病。成藥無需處方箋即可方便地幫助人們應對這些常見疾病。包括維生素、膳食補充劑和保健藥品在內的非處方產品，符合人們追求整體健康和預防與老齡化相關疾病的趨勢。

學名藥的競爭

學名藥的推出，尤其是價格通常低於品牌非處方藥的學名藥，加劇了市場競爭，給老牌製藥公司帶來了壓力。雖然學名藥符合監管標準，但它們會降低品牌非處方藥的利潤率，並縮小其市場佔有率。此外，學名藥的上市可能導致品牌非處方藥失去獨家銷售權，對原廠藥的銷售和利潤產生負面影響。

新冠疫情的影響

疫情期間，人們健康意識的提高、預防措施的加強以及對自我護理產品需求的激增，推動了非處方成藥）銷售的蓬勃發展。隨著消費者尋求常見疾病的解決方案，免疫增強劑、止咳感冒藥和衛生用品的銷售量均有所成長。然而，供應鏈中斷、消費者支出模式的轉變以及經濟的不確定性也帶來了挑戰。疫情凸顯了非處方藥產業適應性和創新能力的重要性，並塑造了消費者行為和市場動態的新趨勢。

在預測期內，鎮痛藥市場預計將佔據最大佔有率。

鎮痛藥預計將佔據最大的市場佔有率。止痛藥是用於疼痛管理和治療的藥物，廣泛用於緩解輕度至中度疼痛，包括常見的成藥），例如對乙醯胺酚、Ibuprofen和阿斯匹靈。這些藥物可以緩解多種疼痛症狀，包括頭痛、肌肉酸痛、月經和輕微關節疼痛。鎮痛藥的特點是易於獲取、使用方便且擁有廣泛的消費者支持，這些因素都極大地促進了整個成藥市場的成長。

在預測期內，平板電腦細分市場預計將呈現最高的複合年成長率。

預計片劑市場在預測期內將實現顯著成長。片劑是藥物的固態壓製製劑，含有活性成分和各種輔料。由於每片片劑都含有標準化量的活性成分，因此可以實現精確的劑量控制。這確保了劑量的一致性，並有助於消費者遵循建議的用藥指南。此外，片劑可用於治療多種疾病，包括疼痛、過敏、消化器官系統問題和營養缺乏症。片劑的便利性、劑量的精確性以及種類繁多的藥物，都促成了片劑在非成藥）市場的廣泛應用和普及。

市佔率最大的地區：

在預測期內，亞太地區佔據最大的市場佔有率，這主要得益於不斷提高的健康意識、可支配收入的增加以及人口的成長。快節奏的生活方式、便利的資訊取得管道以及對非處方箋藥的偏好，都推動了自我治療的顯著趨勢。此外，文化差異、醫療實踐和歷史因素也導致各國在偏好和購買行為上存在差異。對於希望在該地區建立穩固市場地位的公司而言，了解這些細微差別至關重要。

複合年成長率最高的地區：

在預測期內，北美市場預計將實現盈利成長。北美消費者傾向於選擇自我護理和非處方藥（OTC）來解決常見健康問題。這一趨勢的促進因素包括便利性、可近性以及無需處方箋即可治療輕微疾病的願望。北美的法規環境較為完善，美國食品藥物管理局（FDA）和加拿大衛生署負責監管成藥的核准和使用。此外，北美非處方藥市場競爭激烈，許多本土和跨國製藥公司都在爭奪市場佔有率。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球非處方藥市場：依產品分類

  • 止痛藥
  • 消化和腸道藥物
  • 感冒咳嗽藥
  • 維生素和礦物質
  • 皮膚科產品
  • 其他產品

第6章 全球非處方藥市場：依劑型分類

  • 藥片
  • 軟膏
  • 液體
  • 噴
  • 其他劑型

第7章 全球非處方藥市場：依給藥途徑分類

  • 口服
  • 腸外
  • 外用
  • 其他給藥途徑

第8章 全球非處方藥市場：依分銷管道分類

  • 藥局和零售藥房
  • 網路藥房
  • 醫院藥房

第9章 全球非處方藥市場：依最終用戶分類

  • 專科診所
  • 醫院
  • 居家照護
  • 其他最終用戶

第10章 全球非處方藥市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第11章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章：公司簡介

  • Bayer AG
  • Pfizer
  • Takeda Pharmaceutical Company Ltd.
  • Johnson & Johnson Services Inc.
  • Novartis AG
  • Sanofi SA
  • GlaxoSmithKline PLC
  • Reckitt Benckiser Group PLC
  • Boehringer Ingelheim International GmbH
  • Mylan
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd
  • Cipla, Inc
  • Glenmark Pharmaceuticals Ltd
  • Dr. Reddy's Laboratories
  • Alkem Laboratories Limited
  • Viatris, Inc
  • The Blackstone Group, Inc.
  • Aytu Biopharma, Inc.
  • Merck & Co. Inc.
Product Code: SMRC25199

According to Stratistics MRC, the Global Over the Counter Drug Market is accounted for $212.3 billion in 2026 and is expected to reach $364.8 billion by 2034 growing at a CAGR of 7.0% during the forecast period. Over-the-Counter (OTC) drugs refer to medications that are available for purchase without a prescription from a healthcare professional. These drugs play a crucial role in providing accessible and convenient solutions for consumers to address minor health issues like common cold, body pain, allergies and flu, heartburn, acne, and other basic health problems. Acetaminophen, aspirin, antacids, decongestants, antihistamines, and laxatives are the examples of OTC drugs. These drugs are chosen by regulatory agencies in many countries to guarantee that they contain chemicals that are safe and effective when taken without the supervision of a physician.

According to a National Institute of Health report, 93% of adults in the U.S. prefer to treat minor illnesses with over the counter drugs before seeking professional help, and 85% of parents prefer to treat minor illnesses in their children with over the counter drugs before seeking professional help.

Market Dynamics:

Driver:

Growing demand for self-medications

Self-medication becomes increasingly popular as people explore readily accessible remedies without a prescription. These medications are readily available in pharmacies, supermarkets, convenience stores, and increasingly through online platforms. This accessibility allows consumers to easily purchase medications for minor ailments and everyday health concerns. Moreover, affordability is a key advantage of OTC drugs compared to prescription medications. With a focus on affordability and ease of access, the market benefits from consumers' preference for managing minor health issues on their own, contributing to the overall growth of the OTC Drug Market.

Restraint:

Safety concerns

OTC drugs, available without a prescription, pose risks of misuse, abuse, and adverse effects due to self-administration by consumers. As individuals may lack professional medical guidance, there's an increased potential for incorrect dosage, drug interactions, or reliance on OTC options for conditions requiring professional intervention. This raises regulatory scrutiny to ensure consumer safety. Instances of adverse reactions or safety issues may result in product recalls or restrictions, impacting market dynamics.

Opportunity:

Global aging population

As the world's population ages, there is a concurrent increase in the prevalence of age-related health issues and chronic conditions. OTC drugs cater to the rising demand for self-medication among the elderly, offering accessible and cost-effective solutions for common ailments. Moreover, aging is often associated with various health concerns, such as joint pain, arthritis, cardiovascular issues, and digestive problems. OTC drugs provide a convenient solution for managing these common ailments without the need for a prescription. OTC products, including vitamins, supplements, and wellness-focused medications, align with the trend of maintaining overall health and preventing age-related issues.

Threat:

Competition from generic drugs

The introduction of generic substitutes, which are frequently less expensive than branded over-the-counter medications, increases market rivalry and put well-known companies under pressure. Generic options, while meeting regulatory standards, can erode profit margins and diminish the market share of branded OTC drugs. Also, the branded OTC drugs may lose their exclusivity as generic options become available, leading to a reduction in market exclusivity and potentially impacting the sales and revenue of the original products.

Covid-19 Impact

Increased health awareness, preventive measures, and heightened demand for self-care products during the pandemic led to a surge in OTC sales. Consumers sought remedies for common symptoms, boosting sales of immune boosters, cough and cold medications, and hygiene-related products. However, disruptions in the supply chain, changes in consumer spending patterns, and economic uncertainties also presented challenges. The pandemic underscored the importance of adaptability and innovation in the OTC industry, shaping new trends in consumer behaviour and market dynamics.

The analgesics segment is expected to be the largest during the forecast period

The analgesics segment is estimated to hold the largest share. Analgesics are medications used in the management and treatment of pain. Widely used to alleviate mild to moderate pain, analgesics include common OTC drugs such as acetaminophen, ibuprofen, and aspirin. These medications addresses a broad spectrum of pain conditions, including headaches, muscle pain, menstrual cramps, and minor arthritis pain. The analgesics segment is characterized by its accessibility ease of use, and broad consumer acceptance, contributing significantly to the overall OTC drug market's growth

The tablets segment is expected to have the highest CAGR during the forecast period

The tablets segment is anticipated to have lucrative growth during the forecast period. Tablets are solid, compressed forms of medication, containing active ingredients along with various excipients. Tablets offer precise dosage control, with each tablet containing a standardized amount of the active ingredient. This ensures consistency in dosing and helps consumers follow recommended usage guidelines. Moreover, they cater to various therapeutic areas, addressing conditions like pain, allergies, digestive issues, and nutritional deficiencies. The convenience, precision in dosing, and broad range of medications available in tablet form contribute to their widespread use and popularity in the OTC drug market.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing healthcare awareness, rising disposable incomes, and a growing population. There's a notable trend towards self-medication, driven by factors such as busy lifestyles, easy access to information, and a preference for non-prescription solutions. Moreover, preferences and buying behaviours vary across countries due to cultural differences, healthcare practices, and historical factors. Understanding these nuances is essential for companies aiming to establish a strong presence in the region.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period. Consumers in North America often prefer self-care and over-the-counter solutions for common health issues. This trend is driven by factors like convenience, accessibility, and the desire to manage minor ailments without the need for a prescription. The regulatory environment in North America is well-defined, with the U.S. Food and Drug Administration (FDA) and Health Canada overseeing the approval and regulation of OTC drugs. Furthermore, the North American OTC market is highly competitive, with both domestic and multinational pharmaceutical companies vying for market share.

Key players in the market

Some of the key players in the Over the Counter Drug Market include Bayer AG, Pfizer, Takeda Pharmaceutical Company Ltd., Johnson & Johnson Services Inc., Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Boehringer Ingelheim International GmbH, Mylan, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Cipla Inc., Glenmark Pharmaceuticals Ltd, Dr. Reddy's Laboratories, Alkem Laboratories Limited, Viatris, Inc, The Blackstone Group, Inc., Aytu Biopharma, Inc. and Merck & Co. Inc.

Key Developments:

In June 2022, Glenmark Pharmaceuticals Ltd. acquired a portfolio of approved OTC abbreviated new drug applications (ANDAs) in the U.S. from Wockhardt. The acquired ANDAs helped the company expand its OTC portfolio in the U.S.

In June 2021, Bayer announced the approval of Astepro Allergyfrom the U.S. Food and Drug (FDA) as an over the counter (OTC) product for the temporary relief of nasal congestion runny nose and Itchy nose and other respiratory allergies.

Products Covered:

  • Analgesics
  • Digestives & Intestinal Remedies
  • Cold & Cough Remedies
  • Vitamins & Minerals
  • Dermatological Products
  • Other Products

Dosage Forms Covered:

  • Tablets
  • Ointments
  • Liquids
  • Sprays
  • Other Dosage Forms

Route of Administrations Covered:

  • Oral
  • Parenteral
  • Topical
  • Other Routes of Administration

Distribution Channels Covered:

  • Drug Stores & Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies

End Users Covered:

  • Speciality Clinic
  • Hospital
  • Homecare
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Over the Counter Drug Market, By Product

  • 5.1 Introduction
  • 5.2 Analgesics
  • 5.3 Digestives & Intestinal Remedies
  • 5.4 Cold & Cough Remedies
  • 5.5 Vitamins & Minerals
  • 5.6 Dermatological Products
  • 5.7 Other Products

6 Global Over the Counter Drug Market, By Dosage Form

  • 6.1 Introduction
  • 6.2 Tablets
  • 6.3 Ointments
  • 6.4 Liquids
  • 6.5 Sprays
  • 6.6 Other Dosage Forms

7 Global Over the Counter Drug Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Oral
  • 7.3 Parenteral
  • 7.4 Topical
  • 7.5 Other Routes of Administration

8 Global Over the Counter Drug Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Drug Stores & Retail Pharmacies
  • 8.3 Online Pharmacies
  • 8.4 Hospital Pharmacies

9 Global Over the Counter Drug Market, By End User

  • 9.1 Introduction
  • 9.2 Speciality Clinic
  • 9.3 Hospital
  • 9.4 Homecare
  • 9.5 Other End Users

10 Global Over the Counter Drug Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Bayer AG
  • 12.2 Pfizer
  • 12.3 Takeda Pharmaceutical Company Ltd.
  • 12.4 Johnson & Johnson Services Inc.
  • 12.5 Novartis AG
  • 12.6 Sanofi S.A.
  • 12.7 GlaxoSmithKline PLC
  • 12.8 Reckitt Benckiser Group PLC
  • 12.9 Boehringer Ingelheim International GmbH
  • 12.10 Mylan
  • 12.11 Sun Pharmaceutical Industries Ltd
  • 12.12 Teva Pharmaceutical Industries Ltd
  • 12.13 Cipla, Inc
  • 12.14 Glenmark Pharmaceuticals Ltd
  • 12.15 Dr. Reddy's Laboratories
  • 12.16 Alkem Laboratories Limited
  • 12.17 Viatris, Inc
  • 12.18 The Blackstone Group, Inc.
  • 12.19 Aytu Biopharma, Inc.
  • 12.20 Merck & Co. Inc.

List of Tables

  • Table 1 Global Over the Counter Drug Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Over the Counter Drug Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Over the Counter Drug Market Outlook, By Analgesics (2023-2034) ($MN)
  • Table 4 Global Over the Counter Drug Market Outlook, By Digestives & Intestinal Remedies (2023-2034) ($MN)
  • Table 5 Global Over the Counter Drug Market Outlook, By Cold & Cough Remedies (2023-2034) ($MN)
  • Table 6 Global Over the Counter Drug Market Outlook, By Vitamins & Minerals (2023-2034) ($MN)
  • Table 7 Global Over the Counter Drug Market Outlook, By Dermatological Products (2023-2034) ($MN)
  • Table 8 Global Over the Counter Drug Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 9 Global Over the Counter Drug Market Outlook, By Dosage Form (2023-2034) ($MN)
  • Table 10 Global Over the Counter Drug Market Outlook, By Tablets (2023-2034) ($MN)
  • Table 11 Global Over the Counter Drug Market Outlook, By Ointments (2023-2034) ($MN)
  • Table 12 Global Over the Counter Drug Market Outlook, By Liquids (2023-2034) ($MN)
  • Table 13 Global Over the Counter Drug Market Outlook, By Sprays (2023-2034) ($MN)
  • Table 14 Global Over the Counter Drug Market Outlook, By Other Dosage Forms (2023-2034) ($MN)
  • Table 15 Global Over the Counter Drug Market Outlook, By Route of Administration (2023-2034) ($MN)
  • Table 16 Global Over the Counter Drug Market Outlook, By Oral (2023-2034) ($MN)
  • Table 17 Global Over the Counter Drug Market Outlook, By Parenteral (2023-2034) ($MN)
  • Table 18 Global Over the Counter Drug Market Outlook, By Topical (2023-2034) ($MN)
  • Table 19 Global Over the Counter Drug Market Outlook, By Other Routes of Administration (2023-2034) ($MN)
  • Table 20 Global Over the Counter Drug Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 21 Global Over the Counter Drug Market Outlook, By Drug Stores & Retail Pharmacies (2023-2034) ($MN)
  • Table 22 Global Over the Counter Drug Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 23 Global Over the Counter Drug Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 24 Global Over the Counter Drug Market Outlook, By End User (2023-2034) ($MN)
  • Table 25 Global Over the Counter Drug Market Outlook, By Speciality Clinic (2023-2034) ($MN)
  • Table 26 Global Over the Counter Drug Market Outlook, By Hospital (2023-2034) ($MN)
  • Table 27 Global Over the Counter Drug Market Outlook, By Homecare (2023-2034) ($MN)
  • Table 28 Global Over the Counter Drug Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.